Conditions: Prostate Cancer
Keywords: prostate cancer hormone treatment
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 17
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether treatment with Zactima for up to 18 months will prolong the off-treatment interval in patients who are undergoing intermittent androgen deprivation therapy.

Detailed description:

Arms:
arm 1: 300 mg orally, once daily for up to 18 months arm 2: orally, once daily for up to 18 months

Interventions: intervention 1: vandetanib intervention 2: Placebo
Intervention descriptions: intervention 1: 300 mg orally, once daily for up to 18 months intervention 2: None

Protocol document: